Samantha K. Hamrick

Promise and Potential Peril With Lumacaftor for the Trafficking Defective Type 2 Long-QT Syndrome-Causative Variants, p.G604S, p.N633S, and p.R685P, Using Patient-Specific Re-Engineered Cardiomyocytes

Bailey J. O’Hare, C.S. John Kim, Samantha K. Hamrick et al. · Circulation Genomic and Precision Medicine · 2020 · 38 citations · Full text

Medicine, Molecular Genetics, Pharmacology +17

Identification of a Novel Homozygous Multi-Exon Duplication in <i>RYR2</i> Among Children With Exertion-Related Unexplained Sudden Deaths in the Amish Community

David J. Tester, Hannah Bombei, Kristi K. Fitzgerald et al. · JAMA Cardiology · 2020 · 28 citations · Full text

Medicine, Genetics, Molecular Genetics +17

Molecular characterization of the calcium release channel deficiency syndrome

David J. Tester, CS John Kim, Samantha K. Hamrick et al. · JCI Insight · 2020 · 21 citations · Full text

Life Sciences, Cardiology, Genetics +17

Acacetin, a Potent Transient Outward Current Blocker, May Be a Novel Therapeutic for <i>KCND3</i> -Encoded Kv4.3 Gain-of-Function-Associated J-Wave Syndromes

Dan Ye, Wei Zhou, Samantha K. Hamrick et al. · Circulation Genomic and Precision Medicine · 2022 · 16 citations · Full text

Medicine, Cardiology, Pharmacology +17

Single Construct Suppression and Replacement Gene Therapy for the Treatment of All <i>CALM1</i> -, <i>CALM2</i> -, and <i>CALM3</i> -Mediated Arrhythmia Disorders

Samantha K. Hamrick, C.S. John Kim, David J. Tester et al. · Circulation Arrhythmia and Electrophysiology · 2024 · 14 citations

Medicine, Cardiology, Pharmacotherapy +15